Abstract
The effects of hypothyroidism and of daily treatment for up to 21 days with thyroxin (T4, 0.5 μg/100 g body weight) on the fatty acid composition of total lipid, phosphatidylethanolamine, and phosphatidylcholine of rat liver mitochondria were studied. The fatty acid compositions of hypothyroid and euthyroid (control) rats of similar age were compared. The n−6 and n−3 polyunsaturated fatty acids (PUFA) were affected differently by the hypothyroid state. The levels of linoleic (18∶2n−6), γ-linolenic (18∶3n−6) and dihomo-γ-linolenic acids (20∶3n−6) were higher in hypothyroid rats than in controls, while the level of arachidonic acid (20∶4n−6) was lower, which suggests an impairment of the elongase and desaturase activities. The n−3 polyunsaturated fatty acids, eicosapentaenoic (EPA, 20∶5n−3) and docosapentaenoic (22∶5n−3) acids, were higher in hypothyroid rats, whereas the linolenic acid (18∶3n−3) content remained constant. The level of docosahexaenoic acid (DHA, 22∶6n−3) was dramatically decreased in hypothyroid rats, while the levels of C22 n−6 fatty acids were unchanged. The differences were probably due to the competition between n−3 and n−6 PUFA for desaturases, elongases and acyltransferases. When hypothyroid rats were treated with thyroxin, the changes induced by hypothyroidism in the proportions of n−6 fatty acids were rapidly reversed, while the changes in the n−3 fatty acids were only partially reversed. After 21 days of thyroxin treatments, the DHA content was only half as high in hypothyroid rats than in euthyroid rats. These results suggest that the conversion of 18∶2n−6 to 20∶4n−6 is suppressed in the hypothyroid state which favors the transformation of 18∶3n−3 to 20∶5n−3. The marked decrease in DHA content indicates an impairment of the enzymes involved in the DHA metabolism, possibly the n−3 Δ4 desaturase or the acyltransferases. The increased levels of EPA and 22∶5n−3 is consistent with the inhibition of the n−3 pathway at the Δ4 desaturase step. Observed modifications in the fatty acid composition may significantly alter eicosanoid synthesis and membrane functions in hypothyroidism.
Similar content being viewed by others
Abbreviations
- AA:
-
arachidonic acid, 20∶4n−6
- DHA:
-
docosahexaenoic acid, 22∶6n−3
- DPA:
-
docosapentaenoic acid, 22∶5n−3
- EFA:
-
essential fatty acid
- EPA:
-
eicosapentaenoic acid, 20∶5n−3
- FAME:
-
fatty acid methyl ester
- PC:
-
phosphatidylcholine
- PE:
-
phosphatidylethanolamine
- PUFA:
-
polyunsaturated fatty acid(s)
- SEM:
-
standard error of the mean
- T3:
-
3,3′,5-triiodothyronine
- T4:
-
3,3′,5,5′-tetraiodothyronine, thyroxin
- UI:
-
unsaturation index
References
Brand, M.D., and Murphy, M.P. (1987)Biol. Rev. 62, 141–193.
Hoch, F.L. (1988)Prog. Lipid Res. 27, 199–270.
Chen, Y.-D.I., and Hoch, F.L. (1976)Arch. Biochem. Biophys. 172, 741–744.
Platner, W.S., Patnayak, B.C., and Chaffee, R.R.J. (1972)Proc. Soc. Exp. Biol. Med. 140, 857–861.
Patton, J.F., and Platner, W.S. (1970)Am. J. Physiol. 218, 1417–1422.
Shaw, M.J., and Hoch, F.L. (1977)J. Mol. Cell. Cardiol. 9, 749–761.
Hoch, F.L. (1982)J. Mol. Cell. Cardiol. 14, 81–90.
Chen, Y.-D.I., and Hoch, F.L. (1977)Arch. Biochem. Biophys. 181, 470–483.
Hulbert, A.J., Augee, M.L., and Raison, J.K. (1976)Biochim. Biophys. Acta 455, 597–601.
Beleznai, Z., Amler, E., Rauchová, H., Drahota, Z., and Janscik, V. (1989)FEBS Lett. 243, 247–250.
Hafner, R.P., Leake, M.J., and Brand, M.D. (1989)FEBS Lett. 248, 175–178.
Paradies, G., and Ruggiero, F.M. (1989)Arch. Biochem. Biophys. 269, 595–602.
Ves-Losada, A., and Peluffo, R.O. (1989)Lipids 24, 931–935.
Faas, F.H., and Carter, W.J. (1982)Biochem. J. 207, 29–35.
Hoch, F.L., Subramanian, C., Dhopeshwarkar, G.A., and Mead, J.F. (1981)Lipids 16, 328–335.
Shaw, M.J., and Hoch, F.L. (1976)Life Sci. 19, 1359–1364.
Ellefson, R.D., and Mason, H.L. (1964)Endocrinology 75, 179–186.
Faas, F.H., and Carter, W.J. (1981)Biochem. J. 193, 845–852.
de Gòmez Dumm, I.N.T., de Alaniz, M.J.T., and Brenner, R.R. (1977)Adv. Exp. Med. Biol. 83, 609–616.
Kumar, S., Das, D.K., Dorfman, A.E., and Asato, N. (1977)Arch. Biochem. Biophys. 178, 507–516.
Gnoni, G.V., Landriscina, C., and Quagliariello, E. (1978)FEBS Lett. 94, 179–182.
Hoch, F.L. (1982)Prog. Lipid Res. 20, 225–228.
Barlow, S.M., Young, F.V.K., and Duthie, I.F. (1990)Proc. Nutr. Soc. 49, 13–21.
von Schacky, C. (1990)Dtsch. Med. Wschr. 115, 224–231.
Budowski, P. (1988)World Rev. Nutr. Diet 57, 214–274.
Lands, W.E.M. (1986)Fish and Human Health, Academic Press, Orlando.
Herold, M.P., and Kinsella, J.E. (1986)Am. J. Clin. Nutr. 43, 566–598.
Kinsella, J.E., Broughton, K.S., and Whelan, J.W. (1990)J. Nutr. Biochem. 1, 123–141.
Sprecher, H. (1989)J. Intern. Med. 225 (Suppl.), 5–9.
Johnson, D., and Lardy, H.I. (1967)Methods Enzymol. 10, 41–47.
Bligh, E.G., and Dyer, W.J. (1959)Can. J. Biochem. Physiol. 37, 911–917.
Zambrano, F., Fleischer, S., and Fleischer, B. (1975)Biochim. Biophys. Acta 380, 357–369.
Daum, G. (1985)Biochim. Biophys. Acta 822, 1–42.
Holman, R.T. (1971)Prog. Chem. Fats Other Lipids 9, 275–348.
Sanders, T.A.B. (1988)Nutr. Res. Reviews 1, 57–78.
Beare-Rogers, J. (1988)J. Am. Oil Chem. Soc. 65, 91–95.
Landriscina, C., Gnoni, G.V., and Quagliariello, E. (1976)Eur. J. Biochem. 71, 135–143.
Kawashima, Y., and Kozuka, H. (1985)Biochim. Biophys. Acta 834, 118–123.
Mariash, C.N., and Oppenheimer, J.H. (1983) inMolecular Basis of Thyroid Hormone Action (Oppenheimer, J.H., and Samuels, H.H., eds.) pp. 265–292, Academic Press, New York.
Holman, R.T. (1986)Prog. Lipid Res. 25, 29–39.
Garg, M.L., Sebokova, E., Thomson, A.B.R., and Clandinin, M.T. (1988)Biochem. J. 249, 351–356.
Campbell, K.L., and Davis, C.A. (1990)Am. J. Vet. Res. 51, 752–756.
Rosenthal, M.D., Garcia, M.C., Jones, M.R., and Sprecher, H. (1991)Biochim. Biophys. Acta 1083, 29–36.
Willis, A.L. (1981)Nutr. Rev. 39, 289–301.
Lagarde, M., Gualde, N., and Rigoud, M. (1989)Biochem. J. 257, 313–320.
Hoffmann, P., and Mest, H.J. (1987)Biomed. Biochim. Acta 46, 639–650.
Author information
Authors and Affiliations
About this article
Cite this article
Raederstorff, D., Meier, C.A., Moser, U. et al. Hypothyroidism and thyroxin substitution affect the n−3 fatty acid composition of rat liver mitochondria. Lipids 26, 781–787 (1991). https://doi.org/10.1007/BF02536158
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02536158